These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8120529)

  • 1. Inhibition of complement-dependent phagocytosis by autoantibodies against C3b-receptor (CR1) in a case of systemic lupus erythematosus.
    Mir A; Balsalobre B
    J Intern Med; 1994 Mar; 235(3):284-5. PubMed ID: 8120529
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-C3b-receptor (CR1) antibodies in patients with systemic lupus erythematosus.
    Cook JM; Kazatchkine MD; Bourgeois P; Mignon F; Mery JP; Kahn MF
    Clin Immunol Immunopathol; 1986 Jan; 38(1):135-8. PubMed ID: 2934195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
    Wilson JG; Ratnoff WD; Schur PH; Fearon DT
    Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of C3b receptors in the differentiation of discoid lupus erythematosus and systemic lupus erythematosus.
    Tausk F; Harpster E; Gigli I
    Arthritis Rheum; 1990 Jun; 33(6):888-92. PubMed ID: 2141982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of autoantibodies against different histone proteins influences complement-dependent phagocytosis of necrotic cell material by polymorphonuclear leukocytes in systemic lupus erythematosus.
    Gullstrand B; Lefort MH; Tydén H; Jönsen A; Lood C; Johansson A; Jacobsen S; Truedsson L; Bengtsson AA
    J Rheumatol; 2012 Aug; 39(8):1619-27. PubMed ID: 22753651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.
    Mir A; Porteu F; Levy M; Lesavre P; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1988 Sep; 73(3):461-6. PubMed ID: 2974768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients.
    Sadallah S; Hess C; Trendelenburg M; Vedeler C; Lopez-Trascasa M; Schifferli JA
    Clin Exp Immunol; 2003 Jan; 131(1):174-81. PubMed ID: 12519402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.
    Birmingham DJ; Gavit KF; McCarty SM; Yu CY; Rovin BH; Nagaraja HN; Hebert LA
    Clin Exp Immunol; 2006 Feb; 143(2):274-80. PubMed ID: 16412051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function.
    Nilsson B; Ekdahl KN; Svarvare M; Bjelle A; Nilsson UR
    Clin Exp Immunol; 1990 Nov; 82(2):262-7. PubMed ID: 2146995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic tests: C3 receptor (CR1, 2)].
    Okuda N; Seya T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():67-70. PubMed ID: 16111190
    [No Abstract]   [Full Text] [Related]  

  • 11. C3b receptor (CR1) on erythrocytes in various diseases.
    Takemura S; Deguchi M; Ueda M; Yoshida N; Kato H; Yoshikawa T; Sugino S; Kondo M
    Immunol Lett; 1984; 7(6):325-8. PubMed ID: 6233222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients.
    Kremlitzka M; Mácsik-Valent B; Polgár A; Kiss E; Poór G; Erdei A
    J Immunol Res; 2016; 2016():5758192. PubMed ID: 27981054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.
    Yoshida K; Yukiyama Y; Hirose S; Miyamoto T
    Clin Exp Immunol; 1985 Jun; 60(3):613-21. PubMed ID: 3160514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement coating of erythrocytes is reduced following their interaction with neutrophils in vitro without loss of complement receptor 1 (CR1).
    Imrie HJ; Jones DR
    Clin Exp Immunol; 1997 Jul; 109(1):217-22. PubMed ID: 9218847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
    Craig ML; Waitumbi JN; Taylor RP
    J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human C3b receptor.
    Cook J; Kazatchkine M
    Nouv Rev Fr Hematol (1978); 1983; 25(5):297-301. PubMed ID: 6228780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus.
    Fyfe A; Holme ER; Zoma A; Whaley K
    Clin Exp Immunol; 1987 Feb; 67(2):300-8. PubMed ID: 2955969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.